Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

TapImmune Inc (NASDAQ:TPIV)

4.00
Delayed Data
As of Jun 23
 +0.29 / +7.82%
Today’s Change
3.08
Today|||52-Week Range
7.15
+3.09%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Revenue and IncomeNet Revenues0.000.000.000.00--
 
Operating ExpensesGross Income0.000.000.000.00--
General Expenses2.4M2.7M1.6M2.4M
 
 
 
 
 
Research And Development1.2M1.1M456.8K989.1K
 
 
 
 
 
Total Operating Expenses2.4M2.7M1.6M2.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-2.4M-2.7M-1.6M-2.4M
 
 
 
 
 
Extraordinary Credit8.2M684.0K14.5K0.00
 
 
 
 
Extraordinary Charge-70.3K-65.3K0.00-3.0K
 
 
 
 
Other Expenses1.8K0.000.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income6.0M-2.1M-1.6M-2.4M
 
 
 
 
 
Net Income6.0M-2.1M-1.6M-2.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS5.9M7.3M8.4M8.4M
 
 
 
 
 
Shares To Calculate EPS Diluted6.5M7.3M8.4M8.4M
 
 
 
 
 
 
Earnings Per ShareEPS$0.36-$0.29-$0.18-$0.29
 
 
 
 
 
EPS Diluted$0.36-$0.29-$0.19-$0.29